Your browser doesn't support javascript.
loading
Initial-onset acute and chronic recurrent stages are two distinctive courses of Vogt-Koyanagi-Harada disease.
Urzua, Cristhian A; Herbort, Carl; Valenzuela, Rodrigo A; Abu El-Asrar, Ahmed M; Arellanes-Garcia, Lourdes; Schlaen, Ariel; Yamamoto, Joyce; Pavesio, Carlos.
Afiliação
  • Urzua CA; Department of Ophthalmology, Faculty of Medicine, University of Chile, Independencia, 1027, Santiago, Chile. cristhian.urzua@uchile.cl.
  • Herbort C; Laboratory of Ocular and Systemic Autoimmune Diseases, Faculty of Medicine, University of Chile, Santiago, Chile. cristhian.urzua@uchile.cl.
  • Valenzuela RA; Facultad de Medicina, Clinica Alemana-Universidad del Desarrollo, Santiago, Chile. cristhian.urzua@uchile.cl.
  • Abu El-Asrar AM; Retinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialized Care (COS), Clinic Montchoisi Teaching Centre, Lausanne, Switzerland.
  • Arellanes-Garcia L; Department of Ophthalmology, University of Lausanne, Lausanne, Switzerland.
  • Schlaen A; Laboratory of Ocular and Systemic Autoimmune Diseases, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Yamamoto J; Departamento de Ciencias Quimicas y Biologicas, Facultad de Salud, Universidad Bernardo O Higgins, Santiago, Chile.
  • Pavesio C; Department of Ophthalmology, Dr. Nasser Al-Rashid Research Chair in Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
J Ophthalmic Inflamm Infect ; 10(1): 23, 2020 Sep 14.
Article em En | MEDLINE | ID: mdl-32924094
PURPOSE: To describe distinctive stages of Vogt-Koyanagi-Harada (VKH) disease: initial-onset acute versus chronic recurrent disease. METHODS: A comprehensive literature review regarding stages and clinical presentations of VKH disease was conducted. RESULTS: Despite a list of signs that has been described as characteristic features of early or late phases of VKH disease, the current classification -developed by an international committee and published in 2001- does not consider a distinction regarding the time from onset of disease symptoms, and specific findings observed at certain time point from the symptoms presentation and outcomes related to the stage of VKH disease. In that sense, chronic recurrent VKH disease is more refractory to treatment and is associated with a higher rate of complications. Accordingly, this subset of VKH patients has poorer functional and anatomical outcomes than patients with an initial-onset acute disease. CONCLUSIONS: An early clear distinction of VKH phenotype [Initial-onset acute versus chronic recurrent disease] should be considered in each clinical scenario, evaluating the delay in diagnosis and the clinical presentation, since it may help clinicians to perform a correct disease prognosis categorization and thus to make treatment decisions in terms of potential refractoriness or expected clinical outcomes.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Ophthalmic Inflamm Infect Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Chile País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Ophthalmic Inflamm Infect Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Chile País de publicação: Alemanha